SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Nephroplus Healthcare Services Pvt Ltd

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 0 NSE: Hospital & Healthcare Services | Small Cap | Nephroplus Healthcar Share Price

BSE Share Price
Not Listed

Nephroplus Healthcare Services Pvt Ltd

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 0 NSE: Hospital & Healthcare Services | Small Cap | Nephroplus Healthcar Share Price

BSE Share Price
Not Listed
Key Metrics
Valuation Multiples
Market Cap
₹0 Cr.
Current Price
₹0
52-Week Low / High
₹0 / 0
TTM EPS
₹0
TTM Sales
₹40.4 Cr.
Book Value per Share
-
P/E Ratio
0.00
Industry PE
91.4
Price to Book (P/B)
0.00
Price to Sales (P/S)
0.00
EV/EBITDA
0.00
Dividend Yield
NAN%
Profitability Efficiency
Return on Equity (ROE)
-74.59%
Return on Capital Employed (ROCE)
-51.78%
Return on Assets (ROA)
-41.62%
Operating Profit Margin
-39.5%
Net Profit Margin
-53.24%
Gross Profit Margin
-38.3%
Growth Momentum
1-yr vs 3-yr growth
Sales Growth (1 Year)
Improving versus 3-year growth rate
41.1%
Operating Profit Growth (1 Year)
-
-
Net Profit Growth (1 Year)
-
-
Asset Quality
Promoter Holding
%
Pledged shares (%) of Promoter's holding (%)
%
Reserves
₹16 Cr.
Equity
₹0 Cr.
Face Value
₹10
All Time Low / High
- / -

Nephroplus Healthcare Services Pvt stock performance

Key Ratios
mw4me loader

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.

Value Creation

Mar'09Mar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18TTM
ROCE % 0%-44.7%0%-42.8%-37.6%-30.6%-41.5%-33.6%-47.1%-51.8%-

Growth Parameters

Sales 00.1038.712.416.420.728.740.440
Sales YoY Gr.-NA-100%NA185.5%43%32.8%25.7%38.8%41.1%-
Adj EPS 0-1.90-13.9-26.5-20.9-29.3-24-30.7-33.20
YoY Gr.-NANANANANANANANANA-
BVPS (₹) 5.87.13.754.566.545.762.138.154350
Adj Net
Profit
0-0.80-8.7-16.5-13-18.3-15-19.9-21.50
Cash Flow from Ops. 00000-11.3-12.8-13.8-13.3-17-
Debt/CF from Ops. 0000000000-

CAGR

9 Years 5 Years 3 Years 1 Years
Sales NA36.1%35%41.1%
Adj EPS NANANANA
BVPS22.2%-12.1%-17.4%-35.1%
Share Price - - - -

Key Financial Parameters

Mar'09Mar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18TTM
Return on
Equity %
0-45.20-41.2-37.6-30.6-41.6-33.8-47.2-51.90
Op. Profit
Mgn %
0-566.40-296.3-157-82.4-87.5-58-53.6-39.5NAN
Net Profit
Mgn %
0-688.90-286.2-191.2-105.2-111.2-72.6-69.4-53.20
Debt to
Equity
0.80.100000000-
Working Cap
Days
01,06802422622642202262011760
Cash Conv.
Cycle
015044977735428350

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'09Mar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18
Sales00.1103.038.6512.3716.4320.6528.6640.44
Operating Expenses + 00.76011.9922.2422.5730.8032.6344.0656.42
Manufacturing Costs00.060001.111.257.6410.5315.70
Material Costs00.0801.473.414.315.135.718.0511.34
Employee Cost 00.1002.617.096.7911.6011.0613.3818.31
Other Costs 00.5107.9011.7310.3612.828.2312.1011.06
Operating Profit 0-0.650-8.96-13.59-10.20-14.37-11.98-15.41-15.98
Operating Profit Margin (%) --566.0%--296.0%-157.0%-82.4%-87.5%-58.0%-53.8%-39.5%
Other Income + 00.0101.860.801.230.701.400.450.55
Exceptional Items 000-0.37000000
Interest 00.010000.020.050.070.100.06
Depreciation 00.1401.453.754.034.544.334.876.04
Profit Before Tax 0-0.780-8.93-16.54-13.02-18.26-14.99-19.92-21.53
Tax 000-0.01000000
Profit After Tax 0-0.780-8.92-16.54-13.02-18.26-14.99-19.92-21.53
PAT Margin (%) --688.0%--294.0%-191.0%-105.0%-111.0%-72.6%-69.5%-53.2%
Adjusted EPS (₹)0.0-1.90.0-14.3-26.5-20.9-29.3-24.0-30.7-33.2
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%0%0%

Valuation of Nephroplus Healthcar - Standalone

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Analyst's Notes

data not found
No data found!

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'09Mar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18

Equity and Liabilities

Shareholders Fund + 0.013.472.3539.0449.023648.7433.7547.2435.71
Share Capital 0.014.255.3111.2413.7413.7416.2416.2418.7219.48
Reserves 0-0.78-2.9627.8035.2922.2632.5017.5228.5316.23
Debt +00.440.040000000
Long Term Debt00.440.040000000
Short Term Debt0000000000
Minority Interest0000000000
Trade Payables00.160.550.620.650.571.094.236.547.43
Others Liabilities 00.150.983.433.392.565.565.353.952.60
Total Liabilities 0.014.213.9143.0953.0739.1355.3843.3357.7245.75

Fixed Assets

Net Fixed Assets +0.012.932.7716.9620.2218.5715.1714.0519.4621.97
Gross Block0.013.073.4319.0726.0428.4229.4731.6840.9049.58
Accumulated Depreciation00.140.662.105.829.8514.3017.6421.4427.61
CWIP 0002.330.520.840.622.791.600.51
Investments 0000000000
Inventories00.030.050.200.460.700.731.551.282.47
Trade Receivables00.020.120.342.102.863.483.995.928.91
Cash Equivalents 00.180.1220.4323.2510.8928.6311.9219.721.20
Others Assets 01.060.852.836.515.276.759.039.7510.69
Total Assets 0.014.213.9143.0953.0739.1355.3843.3357.7245.75

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18
Cash Flow From Operating Activity + 00-11.31-12.84-13.79-13.28-17.03
PBT 00-13.02-18.26-14.99-19.92-21.53
Adjustment 004.518.023.886.486.92
Changes in Working Capital 00-2.79-2.64-2.33-0.12-3.91
Tax Paid 0000-0.350.271.49
Cash Flow From Investing Activity + 0000-6.92-5.12-8.51
Capex 0000-4.51-9.49-8.81
Net Investments 0000-43.990.01
Others 00001.590.380.29
Cash Flow From Financing Activity + 00-1.0530.57030.207.02
Net Proceeds from Shares 000310010
Net Proceeds from Borrowing 0000000
Interest Paid 0000000
Dividend Paid 0000000
Others 00-1.05-0.43030.20-2.98
Net Cash Flow 00-12.3617.73-20.7111.80-18.52

Financial Ratio

PARTICULARSMar'09Mar'10Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18
Ratios
ROE (%)0-51.660-49.52-43.78-37.18-54.31-47.95-67.78-74.59
ROCE (%)0-44.650-42.76-37.57-30.58-41.46-33.59-47.08-51.78
Asset Turnover Ratio00.0500.130.180.270.350.420.570.78
PAT to CFO Conversion(x)N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Working Capital Days
Receivable Days058.10027.7051.4073.1070.406663.1066.90
Inventory Days084.60014.5013.9017.1015.8020.101816.90
Payable Days0349.800145.106851.7058.90169.90244224.70

Management X-Ray

Shareholding Pattern

No Data To Display

Promoter's Holding & Share Pledging

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Nephroplus Healthcare Services Pvt Ltd FAQs

The current trading price of Nephroplus Healthcar on 01-Jan-1970 05:30 is ₹0.00.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Dec-1969 the market cap of Nephroplus Healthcar stood at ₹0.00 Cr

The latest P/E ratio of Nephroplus Healthcar as of 31-Dec-1969 is 0.00.

The latest P/B ratio of Nephroplus Healthcar as of 31-Dec-1969 is 0.00.

The 52-week high of Nephroplus Healthcar is ₹0.00 and the 52-week low is ₹0.00.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Nephroplus Healthcar is ₹40.44 ( Cr.) .

Data is not available for this company.

No data found

No data found

About Nephroplus Healthcare Services Pvt Ltd

No data to display
You have 0 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: